We also thank the Evidence Review Team members and staff of the National Kidney Foundation who made this project possible. Finally, we owe a special debt of gratitude to the many KDIGO Board members and individuals who volunteered time reviewing the guideline, and making very helpful suggestions. Bertram L Kasiske, MD David C Wheeler, MD, FRCP KDIGO Co-Chair KDIGO Co-Chair http://www.kidney-international.org & 2013 KDIGO Work Group Membership http://www.kidney-international.org & 2013 KDIGO WORK GROUP CO-CHAIRS Marcello A Tonelli, MD, SM, FRCPC University of Alberta Edmonton, Canada Christoph Wanner, MD University of Wu rzburg Wu rzburg, Germany WORK GROUP EVIDENCE REVIEW TEAM Tufts Center for Kidney Disease Guideline Development and Implementation, Tufts Medical Center, Boston, MA, USA: Ashish Upadhyay, MD, Project Director Ethan M Balk, MD, MPH, Program Director, Evidence Based Medicine Amy Earley, BS, Project Coordinator Shana Haynes, MS, DHSc, Research Assistant Jenny Lamont, MS, Project Manager Alan Cass, MBBS, FRACP, PhD Menzies School of Health Research Darwin, Australia Florian Kronenberg, MD Innsbruck Medical University Innsbruck, Austria Amit X Garg, MD, FRCPC, FACP, PhD London Health Sciences Centre London, Canada Rulan S Parekh, MD, MS, FRCPC, FASN Hospital for Sick Children Toronto, Canada Hallvard Holdaas, MD, PhD Hospital Rikshospitalet Oslo, Norway Tetsuo Shoji, MD, PhD Osaka City University Osaka, Japan Alan G Jardine, MBChB, MD, FRCP BHF Cardiovascular Research Centre Glasgow, United Kingdom Robert J Walker, MBChB, MD (Otago), FRACP, FASN, FAHA University of Otago Dunedin, New Zealand Lixin Jiang, MD, PhD Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China Abstract The 2013 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease (CKD) provides guidance on lipid management and treatment for all patients with CKD (non-dialysis-dependent, dialysis-dependent, kidney transplant recipients and children). 